Medicare Advantage Denials Face New Federal Review — 80% Reversed on Appeal
Federal investigators are reviewing how Medicare Advantage plans use prior authorization and step therapy for Part B drugs. What the review covers, what the 52.8 million decisions and 80.7% appeal-reversal rate actually show, and what to do if your care is denied.